Related Experiment Video
Updated: Jan 10, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Hyperuricemia as an Early Indicator of Cardiovascular Risk in the General Population
Fady Al-Azem1,2, Bastian Schrader2, Joachim Schrader1
1Department of Internal Medicine and Nephrology, St.-Josefs-Hospital, 49661 Cloppenburg, Germany.
Insights
Elevated serum uric acid levels are linked to increased cardiovascular events and risk factors. Routine uric acid measurement can help identify high-risk patients for early intervention.
Area of Science:
- Cardiology
- Nephrology
- Metabolic Diseases
Background:
- Prospective cohort study investigating hyperuricemia (HU) and cardiovascular diseases.
- Assesses the correlation between elevated uric acid levels and cardiovascular risk.
- Examines future cardiovascular event incidence in relation to serum uric acid.
Purpose of the Study:
- To determine the association between hyperuricemia and cardiovascular risk.
- To evaluate the link between hyperuricemia and future cardiovascular events.
- To assess the role of serum uric acid levels in cardiovascular morbidity and mortality.
Main Methods:
- Analysis of data from 4082 participants.
- Division of participants into two groups based on serum uric acid levels.
- Comparison of cardiovascular event incidence between groups.
Main Results:
- Participants with elevated serum uric acid showed significantly higher incidence of coronary artery disease, stroke, heart failure, and chronic kidney insufficiency.
- Higher serum uric acid levels correlated with increased prevalence of hypertension, obesity, and diabetes.
- Hyperuricemia identified as a potential independent risk factor for cardiovascular morbidity and mortality.
Conclusions:
- Routine measurement of uric acid levels can aid in early identification of high-risk cardiovascular patients.
- Hyperuricemia may be a marker for metabolic dysfunction and an independent cardiovascular risk factor.
- Further research is needed on the benefits of xanthine oxidase inhibitor (XOI) therapy for cardiovascular event reduction.
Abstract:
Background: This prospective cohort study examines the association between hyperuricemia (HU) and cardiovascular diseases. The aim of the current study was to assess whether there might be a correlation between hyperuricemia and cardiovascular risk and future cardiovascular events. Methods: We analyzed data from 4082 participants, dividing them into two groups based on serum uric acid levels. Results: Our findings reveal that participants with elevated serum uric acid or xanthine oxidase inhibitor (XOI) therapy had a significantly higher incidence of cardiovascular events such as coronary artery disease (8.4% vs. 3.3%), stroke (2.6% vs. 1.2%), heart failure (3.4% vs. 0.9%), and chronic kidney insufficiency (4.5% vs. 1.9%) compared to those with normal uric acid levels. Moreover, group 2, which had higher serum uric acid levels, also exhibited a higher burden of established cardiovascular risk factors, including hypertension, obesity, and diabetes. These results support the hypothesis that HU is not only a marker for metabolic dysfunction but may also serve as an independent risk factor for cardiovascular morbidity and mortality. Conclusions: We propose that routine measurement of uric acid levels could be a valuable tool for early identification of high-risk cardiovascular patients, particularly in individuals with multiple metabolic risk factors. Further prospective studies are needed to explore the potential benefits of early XOI therapy in reducing cardiovascular events.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Coronary Artery Disease I: Introduction
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:26Coronary Artery Disease IV: Preventive Measures
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...